Phosphodiesterase inhibitor - PDFSEARCH.IO - Document Search Engine

Phosphodiesterase inhibitor
Results: 46

#	Item
11	HIGHLIGHTS OF PRESCRIBING INFORMATION • These highlights do not include all the information needed to use ADCIRCA safely and effectively. See full prescribing information Add to Reading List Source URL: pi.lilly.com Language: English - Date: 2014-05-09 10:20:27 Eli Lilly and Company PDE5 inhibitors Tadalafil Organochlorides Amines CGMP-specific phosphodiesterase type 5 Pulmonary hypertension Phosphodiesterase inhibitor Oxazepam Lactams Chemistry Organic chemistry
12	Tadalafil (Adcirca®) Issued by PHA’s Scientific Leadership Council Information is based on the United States Food and Drug Administration drug labeling Last Updated November[removed]WHAT IS TADALAFIL? Add to Reading List Source URL: phassociation.org Language: English - Date: 2013-12-03 14:16:11 Lactams PDE5 inhibitors Tadalafil Human sexuality CGMP-specific phosphodiesterase type 5 Pulmonary hypertension Erectile dysfunction Phosphodiesterase inhibitor High altitude pulmonary edema Eli Lilly and Company Chemistry Organic chemistry
13	Tadalafil (Adcirca®) Issued by PHA’s Scientific Leadership Council Information is based on the United States Food and Drug Administration drug labeling Last Updated November[removed]WHAT IS TADALAFIL? Add to Reading List Source URL: www.phassociation.org Language: English - Date: 2013-12-03 14:16:11 Lactams PDE5 inhibitors Tadalafil Human sexuality CGMP-specific phosphodiesterase type 5 Pulmonary hypertension Erectile dysfunction Phosphodiesterase inhibitor High altitude pulmonary edema Eli Lilly and Company Chemistry Organic chemistry
14	District of Columbia EHB Benchmark Plan Add to Reading List Source URL: www.cms.gov Language: English - Date: 2013-05-05 06:18:41 Anti-diabetic medication Chemotherapy Leukotriene antagonist Analgesic Quinolone Muscle relaxant Phosphodiesterase inhibitor ACE inhibitor Antihypertensive drug Medicine Antibacterial Antibiotics
15	Briefing Book - April 2010 Add to Reading List Source URL: www.fda.gov Language: English Chronic lower respiratory diseases Chronic obstructive pulmonary disease Smoking Phosphodiesterase-4 inhibitor Acute exacerbation of chronic obstructive pulmonary disease Roflumilast Spirometry Tiotropium bromide Pulmonology Respiratory therapy Medicine
16	Docket No. OON[removed]Dockets Management Branch (HFA-305) Food and Drug Administration 5630 Fishers Lane rm[removed]Rockville Add to Reading List Source URL: www.fda.gov Language: English - Date: 2000-10-23 04:30:37 Pathology MRCVS Newsholme Veterinary physician University of the Philippines Los Baños College of Veterinary Medicine Phosphodiesterase-4 inhibitor Medicine Veterinary pathology Veterinary medicine
17	Effects of cAMP-dependent protein kinase activator and inhibitor on in vivo rolipram binding to phosphodiesterase 4 in conscious rats Add to Reading List Source URL: intramural.nimh.nih.gov Language: English - Date: 2010-01-04 11:40:27 Neuroimaging Molecular biology Signal transduction Rolipram Phosphodiesterase-4 inhibitor Neurotransmitters Positron emission tomography Protein kinase A Phosphodiesterase 4 Biology Medicine Biochemistry
18	Phosphodiesterase 4D is required for ␤2 adrenoceptor subtype-specific signaling in cardiac myocytes Yang Xiang†, Fabio Naro†‡§, Maria Zoudilova‡, S.-L. Catherine Jin‡, Marco Conti‡¶, and Brian Kobilka¶ Add to Reading List Source URL: med.stanford.edu Language: English - Date: 2009-12-04 19:10:48 Phosphodiesterase inhibitor Amrinone CGMP-specific phosphodiesterase type 5 Phosphodiesterase Phospholamban Rolipram Heart failure Myocyte CAMP-dependent pathway Biology Phosphodiesterase-4 inhibitor Pyridines
19	PRIOR AUTHORIZATION POLICY Otezla® (apremilast tablets – Celgene Corporation) To Initiate a Coverage Review, Call[removed]OVERVIEW Otezla, a phosphodiesterase 4 (PDE4) inhibitor, is indicated for treatment of a Add to Reading List Source URL: statehealthplan.state.nc.us Language: English - Date: 2014-05-29 15:15:36 Pharmacology Adalimumab Psoriasis Leflunomide Ustekinumab Psoriatic arthritis Etanercept Golimumab Infliximab Immunosuppressants Medicine Immunology
20	V Contents Preface XV Introduction XVII Abbreviations XXI Add to Reading List Source URL: www.wiley-vch.de Language: English - Date: 2010-06-24 21:03:59 Lactams CGMP-specific phosphodiesterase type 5 Rifamycin Camptothecin Protease inhibitor Zaprinast Organic chemistry Pharmacology PDE5 inhibitors Chemistry ACE inhibitors

UPDATE